Earnings › Elevance Health · Elevance Health company page · insider trades

Elevance Health earnings

Elevance Health (ELV) quarterly revenue, net income and diluted EPS from its SEC filings, the upcoming report date, and links to each earnings release. Last update 2026-10-14.

Elevance Health (ELV) will report third quarter 2026 results on Wednesday, Oct 21, 2026, 6:00 a.m. EDT; call 8:30 a.m. EDT, according to Elevance Health. See all Q3 2026 earnings dates.

Subscribe to Elevance Health earnings dates in your calendar app (updates automatically)

Also reporting that week

Quarterly results

Quarter Revenue YoY Net income YoY Diluted EPS
Q2 2026 ended Jun 30, 2026 $50.47B +1% $1.46B −16% $6.71
Q1 2026 ended Mar 31, 2026 $50.18B +3% $1.76B −19% $8.00
Q4 2025 ended Dec 31, 2025 · from annual report $49.75B +9% $547.0M +31% —
Q3 2025 ended Sep 30, 2025 $50.71B +12% $1.19B +17% $5.32
Q2 2025 ended Jun 30, 2025 $49.78B — $1.74B — $7.72
Q1 2025 ended Mar 31, 2025 $48.89B — $2.18B — $9.61
Q4 2024 ended Dec 31, 2024 · from annual report $45.44B — $418.0M — —
Q3 2024 ended Sep 30, 2024 $45.11B — $1.02B — $4.36

Earnings releases (Form 8-K, Item 2.02)

Source: SEC EDGAR XBRL company facts (10-Q and 10-K) and 8-K filings. Quarters marked "from annual report" are the annual total minus the three reported quarters, because Elevance Health reports its fourth quarter only inside the annual report; EPS is not derived for those quarters. Figures are as reported under US GAAP. Not investment advice.

FAQ

Q When is Elevance Health's next earnings date?

A Elevance Health (ELV) will report third quarter 2026 results on Wednesday, Oct 21, 2026, 6:00 a.m. EDT; call 8:30 a.m. EDT, according to Elevance Health.

Q What time does Elevance Health report earnings?

A 6:00 a.m. EDT; call 8:30 a.m. EDT, per Elevance Health.

Q Where can I listen to Elevance Health's earnings call?

A Elevance Health hosts the webcast on its investor relations site: https://www.elevancehealth.com

Q What were Elevance Health's latest quarterly results?

A For Q2 2026 (ended Jun 30, 2026), Elevance Health reported revenue of $50.47B and net income of $1.46B, or $6.71 per diluted share, according to its 10-Q filed Jul 15, 2026.